Top Markets
Coin of the day
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
शेयरों में रैंक #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
शेयर मूल्य
$0.12164306
अंतिम समन्वयन: 2024-11-11
मार्केट कैप
$38.53M
बदलाव (1 दिन)
-4.14%
बदलाव (1 वर्ष)
0.00%
देश
AU
व्यापार PharmAust Limited (PAA)

श्रेणी

PharmAust Limited (PAA) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $0.12 (2024-11-01 को)

दिन का सबसे निम्न समापन मूल्य: $3.11 (2001-10-01 को)
PharmAust Limited के स्टॉक मूल्य का इतिहास 2001 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
वर्ष प्रदर्शन
2024 72.79%
2023 61.50%
2022 -33.17%
2021 -20.54%
2020 20.68%
2019 171.67%
2018 -30.35%
2017 4.90%
2016 -29.98%
2015 -55.93%
2014 -33.04%
2013 25.44%
2012 -54.31%
2011 -8.75%
2010 -46.71%
2009 152.12%
2008 -65.75%
2007 -55.38%
2006 -27.70%
2005 -34.70%
2004 20.98%
2003 69.43%
2002 -28.84%
2001 0.00%
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
कंपनी स्टॉक मूल्य परिवर्तन 1व% देश
$546.39 38.55%
US
$1.03K 56.51%
NL
$120.74 -14.98%
AU
$142.97 431.68%
US
$763.17 7.23%
CH